Showing results (1071-1080 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|October 2, 2025
Tryptophan derivatives as non-invasive diagnostic indicators for obesity-related MASLD in children and adolescentsShumin Zhan, Xingyun Wang, Chen Wang, et al.
Diabetes, Obesity & Metabolism|September 29, 2025
The estrous cycle moderates the food and body weight suppressive effects of glucagon-like peptide-1 receptor agonismSarah V Applebey, Allison G Xiao, Benjamin C Reiner, et al.
Diabetes, Obesity & Metabolism|September 29, 2025
An interpretable machine learning model for predicting metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetesZhuolin Zhou, Nan Gao, Jiaojiao Liu, et al.
Diabetes, Obesity & Metabolism|September 29, 2025
Comparative cardiovascular risk of sulfonylureas with low- and high-affinities for cardiac mitochondrial adenosine triphosphate-sensitive potassium channels versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A cohort studyMei-Hsiu Chen, Liang-Yu Lin, Tung-Ying Hung, et al.
Diabetes, Obesity & Metabolism|September 29, 2025
Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three-year SURMOUNT-1 trialEmily R Hankosky, Jeremie Lebrec, Clare J Lee, et al.
Diabetes, Obesity & Metabolism|September 30, 2025
ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swineSara Russo, Luca Proto, Manoel Galvao Neto, et al.
Diabetes, Obesity & Metabolism|May 9, 2020
Bolus insulin dose depends on previous-day race intensity during 5 days of professional road-cycle racing in athletes with type 1 diabetes: A prospective observational studyOthmar Moser, Marlene Dietrich, Olivia McCarthy, et al.
Diabetes, Obesity & Metabolism|May 9, 2020
Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort studyAnat Fisher, Michael Fralick, Kristian B Filion, et al.
Diabetes, Obesity & Metabolism|September 14, 2021
Understanding the place for GLP-1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selectionChristine Rode Andreasen, Andreas Andersen, Filip Krag Knop, et al.
Diabetes, Obesity & Metabolism|August 31, 2021
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trialsSøren S Lund, Naveed Sattar, Afshin Salsali, et al.
Pageof 632